ValiRx Share News (VAL)

ValiRx Information

Buy VAL Shares
Add VAL to Watchlist
Add VAL to Alert

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 2.95

Bid: 2.90

Ask: 3.00

Change: 0.00 (0.00%)

Spread: 0.10 (3.448%)

Open: 2.95

High: 2.95

Low: 2.95

Prev. Close: 2.95

Last checked at -

ValiRx Raises GBP1M Through Placing; Shares Fall Toward Placing Price

Fri, 15th Nov 2013 10:28

LONDON (Alliance News) - Pharmaceutical company ValiRx PLC Friday said that it has raised GBP1 million in a placing of 307.7 million shares with institutional and other investors.

The cancer drug developer said that it will use the funds to further advance its development programmes.

The shares were priced at 0.325 pence per share. Following the placing, ValiRx has 2.0 million shares issued.

ValiRx shares were amongst the biggest decliners Friday morning, down 18% at 0.352 pence per share.

By Rowena Harris-Doughty; rowenaharrisdoughty@alliancenews.com; @rharrisdoughty

More News

2 Feb 2012 12:17

Small caps round-up: Caza, Tower Resources, Noventa...

Mining firm Noventa says that operations have suffered from a "plague" of beetles as a result of tropical storms which have hit the firm's Marropino site in Mozambique over the past 10 days. The Rove Beetle is very poisonous and around 30% of the workforce at Marropino have been affected by the seve

15 Dec 2011 09:21

Valirx wins Canadian patent for 'gene-silencing' technology

ValiRx, the AIM listed life sciences firm, saw its share price surge on news that its 'gene-silencing' technology has received patent approval in Canada. It already has patents for the US, Europe and Australia. ValiRx is developing treatments which "silence" so called rebellious genes that can cau

15 Jul 2010 07:40

ValiRx Begins Clinical Validation Of HPV Test

LONDON (Dow Jones)--ValiRx PLC (VAL.LN), a life science company with a focus on cancer diagnostics and therapeutics for personalized medicine, said Thursday its human papilloma virus, or HPV, smear test to detect the onset of cervical cancer in women has now begun clinical sample validation. MAI

17 Jun 2010 08:14

Small caps round-up: Nyota Minerals, Mariana Resources, Bluestar...

Miner Nyota Minerals said drilling at its flagship Tulu Kapi gold project in Ethiopia has confirmed the presence of a new mineralized structure beneath the inferred resource of 1.38m ounces of gold. Also in gold mining, Mariana Resources said it made an encouraging intersection of gold north of the

17 Jun 2010 07:36

ValiRx Completes 1st Yr Eurostars Program, All Milestones Met

LONDON (Dow Jones)--ValiRx Plc (VAL.LN), a life science company with a focus on cancer diagnostics and therapeutics for personalized medicine, announced Thursday that it has completed the first year of a two year Eurostars grant program (total budget EUR1.2 million) in which all developmental milest

24 May 2010 13:42

London afternoon: Back to square one

Footsie has limped back into positive territory, helped by an about turn by the mining stocks. After spending the morning down in the dumps Rio Tinto is now the best performing mining stock as metal prices head northwards. Fellow mining stocks Xstrata and Anglo American join Rio on the rise but S

24 May 2010 07:52

Small caps: Cineworld, Aortech, African Eagle

Cinema chain Cineworld has signed a deal with Quintain Estates for a new multi-screen cinema at Wembley City, the retail park next door to Wembley station. Cineworld has signed a 25 year lease for a new nine screen cinema which will seat 1,800 people in total and is scheduled to open in 2013. It w

9 Mar 2010 14:31

Small caps round-up: Chaarat Gold, Leed Petroleum, Zotefoams...

Gold explorer Chaarat continues its year-long rally after increasing resources at its 100%-owned Chaarat deposit in the Kyrgyz Republic from 3.3m to 4m ounces. "This continues to demonstrate the significant potential of the deposit which will allow the company to pursue a low cost gold mining opera

14 Sep 2009 14:00

Sector movers: Chemical sector reacts to Johnson Matthey downgrade

Johnson Matthey is helping drag the chemicals sector lower. The platinum refiner and catalytic converter maker was downgraded to 'equal-weight' from 'overweight' at Morgan Stanley. Elsewhere in chemicals, Plant Health Care falls back slightly after depressed agricultural markets resulted in widenin

14 Sep 2009 09:51

Small caps round-up: IS Solutions, Netservices, Plant Health Care...

Higher revenues helped software services group IS Solutions post broadly unchanged profits in the six months to June 30. Pre-tax profits for the period totalled £184,000, compared with £189,000 the previous year, as revenues soared to £5.12m from £3.64m. During the year, the company completed the p

Latest Share Chat

ValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ValiRx Raises GBP1M Through Placing; Shares Fall Toward Placing Price

Login to your account

Quickpicks are a member only feature

Login to your account